Amantadine treatment for cocaine-dependent patients with severe withdrawal symptoms

Author: Kampman, Kyle M

Source: Expert Review of Neurotherapeutics, Volume 2, Number 5, September 2002 , pp. 601-608(8)

Buy & download fulltext article:

Price: $73.00 plus tax (Refund Policy)

Abstract:

Despite a tremendous research effort, there are no medications currently approved for the treatment of cocaine dependence. Cocaine-dependent patients vary widely in clinical characteristics and response to treatment. This heterogeneity may partially account for the inability to find an effective medication. The identification of specific traits that predict response to particular therapies would be extremely useful in the search for a medication. Cocaine withdrawal symptom severity may predict response to medications that relieve cocaine withdrawal symptoms, such as amantadine. This paper describes a method of measuring cocaine withdrawal symptom severity and presents preliminary evidence demonstrating that amantadine may assist patients with more severe cocaine withdrawal symptoms achieve abstinence from cocaine.

Keywords: amantadine; cocaine; dopamine; drug dependence; drug withdrawal syndrome

Document Type: Drug Evaluation

DOI: http://dx.doi.org/10.1586/14737175.2.5.601

Publication date: 2002-09-01

More about this publication?

Expert Review of Neurotherapeutics provides expert commentary on the use of drugs and medicines in clinical neurology and neuropsychiatry. Coverage includes disease management, new medicines and drugs in neurology, therapeutic indications, diagnostics, medical treatment guidelines and neurological diseases such as stroke, epilepsy, Alzheimer's and Parkinson's.
Editorial Board
Information for Authors
Submit a Paper
Subscribe to this Title
Information for Advertisers
Terms & Conditions
Information for Librarians
Free Trials
ingentaconnect is not responsible for the content or availability of external websites